Announcing the 4th Edition Drug Safety Symposium 2025

With patient safety becoming more critical than ever in today's evolving healthcare landscape, the demand for robust drug safety practices continues to surge. After several successful editions in India and Dubai, Eminence Group returns with 4th Edition Drug Safety Symposium 2025 – India Chapter, reaffirming its place as one of the most anticipated PV platforms in the region. What began as a knowledge-sharing initiative has grown into a dynamic, solutions-focused gathering where pharmacovigilance (PV), regulatory affairs, clinical safety, QA, and MAH professionals come together to solve real-time challenges, align on regulatory shifts, and co-create the future of drug safety.

With each edition, this platform has evolved to become not just a conference, but a community and movement, a space where cross-functional stakeholders move beyond titles and departments to drive meaningful conversations and collaboration. As patient safety gains global focus, the 2025 edition will explore the theme: ‘Beyond Compliance: Creating a Future-Ready, Globally Aligned PV Ecosystem’.

What Makes DSS 2025 Exceptional?

Hands-On Learning:Whether it’s mastering IDMP transitions, understanding AI opportunities & limitations in signal management, or decoding inspection findings across ROW countries like Peru, Mexico, Ukraine, DSS offers interactive training sessions that go beyond presentations. Experts will demystify CSV documentation, PSMF integration across UK, Europe, and India, and conduct live tool demos to ensure attendees walk away with practical knowledge they can apply immediately.

Open Discussion Forums:From integration of medical information & PV to QPPV process excellence, DSS introduces no-barrier panels where questions are welcomed and real-world challenges are dissected. Expect transparent discussions from industry stalwarts on inspections, REMS in ROW markets, and talent retention in a competitive PV ecosystem.

Multi-Stakeholder Engagement:We’re inviting industry leaders from pharma sector, regulatory bodies, and innovative service providers to tackle futuristic topics like This year's sessions aim to address biologics & vaccine guidelines, the growing role of Global Capability Centers (GCCs), and biosimilar safety.

Stakeholder-Centric Sessions Include:

• XEVMPD to IDMP Transition: What Indian PV Teams Must Know
• AI in Signal Management: Limitations, Possibilities & What Still Needs Human Intervention
• PSMF Across Geographies: From Local to Global Integration
• Real-World Evidence (RWE): Navigating the How’s and Why’s
• Vendor Management & Stakeholder Collaboration: Practical Approaches
• Talent Management & Future Workforce Planning in PV

This is more than a symposium; it’s a movement toward redefining pharmacovigilance as a strategic pillar of drug development and patient safety.